A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome

NCT01427816 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: KCT-0809
DRUG: KCT-0809
DRUG: Placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.